Clinical features of COVID-19 rapid antigen test exposures reported by an Australian poisons information centre: a prospective study.

In this prospective series, few patients developed symptoms, regardless of the sodium azide content, likely due to low concentration and low volume within the test kits. However, ongoing toxicovigilance is warranted.